Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy

Introduction: The second-generation 5-hydroxytryptamine-3 (5-HT(3)) receptor antagonist palonosetron is effective in the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with highly and moderately emetogenic chemotherapy (HEC and MEC, respectively). In addition, palonosetron...

Descripción completa

Detalles Bibliográficos
Autores principales: Celio, Luigi, Niger, Monica, Ricchini, Francesca, Agustoni, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554402/
https://www.ncbi.nlm.nih.gov/pubmed/26345982
http://dx.doi.org/10.2147/CE.S65555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554402/
https://www.ncbi.nlm.nih.gov/pubmed/26345982
http://dx.doi.org/10.2147/CE.S65555

Ejemplares similares